Vilacto Bio Inc. Launches Affiliate Program for Its Award-Winning Skincare Products

Vilacto Bio Inc. Launches Affiliate Program for Its Award-Winning Skincare Products

COPENHAGEN, Denmark, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI), announces today the launch of an Affiliate Program for its patented and award-winning ?Lactoactive? formulated Vilact Skin Care products.

Vilacto Bio Inc. now provides the opportunity for top health & beauty bloggers, writers and commentators to offer the company's leading skin care products to their readers & followers through its partnership with the Rakuten / LinkShare affiliate network.

The affiliate or associate program will provide a mutual benefit to both Vilacto and its Affiliates. Affiliate programs are arrangements in which an online merchant website such as Vilacto Bio, pays affiliate websites to send them traffic. These affiliate websites will post links to Vilacto's website and in turn will be paid a commission.

Affiliate Program partners are now able to monetize their health & beauty blogs, Twitter and Instagram feeds, Facebook pages, YouTube channels, and email lists by promoting the award-winning Lactoactive Skin Care formula that recently won Scandinavia's ?Best New Natural Skincare Product? award.

?We are proud of our new Affiliate Program,? says Vilacto Bio CEO Gert Andersen, ?as it offers Affiliates unique value-added benefits by giving them access to a new line of premiere skincare products that their readers and followers will discover for the first time via the Affiliates' own branded media channels.?

Applying for the new Affiliate Program is fast, simple and free through the company's ecommerce portal at: https://vilacto.com/affiliate-program/. Once approved, Affiliates have quick & easy access to promotional materials & links, commission reports, and a Dedicated Affiliate Manager.

About Vilacto Bio Inc.:                                                                                                                              

Vilacto Bio Inc. (OTC QB:VIBI), is a biotech company that has developed the now fully patented Lactoactive^® (Lactoactive molecule) that in numerous studies has demonstrated above average effect treating conditions such as inflammatory diseases, diabetes, psoriasis, skin aging, and skin issues in different levels. We aim to further develop our Lactoactive^® molecule for the purpose of increasing the quality of our retail and medical skin cream products as well as licensing out our Lactoactive^® molecule for the pharmaceutical industry.

Vilacto Bio Inc.
Fabriksvej 48
4700 Naestved
Denmark

Gert Andersen
Phone: +1 646-893-7895
[email protected]
www.vilactobio.com

Forward-Looking Statements & Disclaimers:

The information in this Press Release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws, as that term is defined in section 27a of the United States Securities Act of 1933, as amended, and section 21e of the United States Securities Exchange Act of 1934, as amended. Statements in this document, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.